Boston Private Bank & Trust’s Novartis NVS Stock Holding History

Boston Private Bank & Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$10.1M	Buy	114,057 +9,133	+9%	+$810K	0.46%	71
2014 Q4	$8.71M	Sell	104,924 -7,317	-7%	-$607K	0.4%	83
2014 Q3	$9.47M	Sell	112,241 -20,406	-15%	-$1.65M	0.46%	73
2014 Q2	$10.8M	Sell	132,647 -85,451	-39%	-$6.72M	0.52%	63
2014 Q1	$16.6M	Buy	218,098 +2,286	+1%	+$167K	0.84%	34
2013 Q4	$15.5M	Buy	215,812 +70,199	+48%	+$4.88M	0.78%	40
2013 Q3	$10M	Buy	145,613 +9,797	+7%	+$648K	0.56%	59
2013 Q2	$8.61M	Buy	+135,816	New	+$8.84M	0.5%	64

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Private Bank & Trust's NVS Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Novartis (NVS) stake by 8.7% in Q1 2015, buying an estimated $810K and bringing the position to 114,057 shares worth $10.1M. The position accounts for 0.46% of the portfolio, ranked #71.

Boston Private Bank & Trust first reported a position in NVS in Q2 2013 and has held it in 8 quarters since. The position peaked at $16.6M in Q1 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Boston Private Bank & Trust held 114,057 shares of Novartis worth $10.1M as of Q1 2015.
Boston Private Bank & Trust bought 9,133 Novartis shares in Q1 2015, an estimated $810K.
Novartis made up 0.46% of Boston Private Bank & Trust's portfolio in Q1 2015, its #71 holding.
Boston Private Bank & Trust first reported a position in Novartis in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Novartis position peaked at $16.6M in Q1 2014.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.